BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19779958)

  • 1. Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment.
    Tfelt-Hansen PC
    J Headache Pain; 2009 Dec; 10(6):389-91. PubMed ID: 19779958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there an inherent limit to acute migraine treatment efficacy?
    Bigal ME; Ho TW
    J Headache Pain; 2009 Dec; 10(6):393-4. PubMed ID: 19820895
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system.
    Link AS; Kuris A; Edvinsson L
    J Headache Pain; 2008 Feb; 9(1):5-12. PubMed ID: 18217201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGRP receptors in the control of pain and inflammation.
    Benemei S; Nicoletti P; Capone JG; Geppetti P
    Curr Opin Pharmacol; 2009 Feb; 9(1):9-14. PubMed ID: 19157980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.
    Durham PL; Vause CV
    CNS Drugs; 2010 Jul; 24(7):539-48. PubMed ID: 20433208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin gene-related peptide receptor antagonists for the treatment of migraine: a patent review.
    Paone DV; Staas DD
    Expert Opin Ther Pat; 2009 Dec; 19(12):1675-713. PubMed ID: 19939188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CGRP antagonists: hope for a new era in acute migraine treatment.
    Schelstraete C; Paemeleire K
    Acta Neurol Belg; 2009 Dec; 109(4):252-61. PubMed ID: 20120204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CGRP receptor antagonists: an expanding drug class for acute migraine?
    Negro A; Lionetto L; Simmaco M; Martelletti P
    Expert Opin Investig Drugs; 2012 Jun; 21(6):807-18. PubMed ID: 22512641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CGRP-receptor antagonism in migraine treatment.
    Edvinsson L
    Lancet; 2008 Dec; 372(9656):2089-90. PubMed ID: 19036426
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
    Hargreaves R; Olesen J
    Headache; 2019 Jun; 59(6):951-970. PubMed ID: 31020659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin gene-related peptide receptor antagonists for migraine.
    Fischer MJ
    Expert Opin Investig Drugs; 2010 Jul; 19(7):815-23. PubMed ID: 20482328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
    Ho TW; Ferrari MD; Dodick DW; Galet V; Kost J; Fan X; Leibensperger H; Froman S; Assaid C; Lines C; Koppen H; Winner PK
    Lancet; 2008 Dec; 372(9656):2115-23. PubMed ID: 19036425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tortuous road to an ideal CGRP function blocker for the treatment of migraine.
    Davis CD; Xu C
    Curr Top Med Chem; 2008; 8(16):1468-79. PubMed ID: 18991732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.
    Villalón CM; Olesen J
    Pharmacol Ther; 2009 Dec; 124(3):309-23. PubMed ID: 19796656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CGRP antagonists: unravelling the role of CGRP in migraine.
    Doods H; Arndt K; Rudolf K; Just S
    Trends Pharmacol Sci; 2007 Nov; 28(11):580-7. PubMed ID: 17963849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding.
    Moore EL; Gingell JJ; Kane SA; Hay DL; Salvatore CA
    Biochem Biophys Res Commun; 2010 Mar; 394(1):141-5. PubMed ID: 20188075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine.
    Tepper SJ; Stillman MJ
    Headache; 2008 Sep; 48(8):1259-68. PubMed ID: 18808506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries.
    Sheykhzade M; Amandi N; Pla MV; Abdolalizadeh B; Sams A; Warfvinge K; Edvinsson L; Pickering DS
    Vascul Pharmacol; 2017 Mar; 90():36-43. PubMed ID: 28192258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGRP receptor antagonists: a new choice for acute treatment of migraine?
    Durham PL
    Curr Opin Investig Drugs; 2004 Jul; 5(7):731-5. PubMed ID: 15298069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CGRP antagonists: novel concept for treatment of migraine].
    Nieber K
    Med Monatsschr Pharm; 2009 May; 32(5):182-5. PubMed ID: 19469188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.